Headquarters
7014 13TH AVE STE 202, BROOKLYN, NY 11228-1604, US
BROOKLYN, NY, US
CORVIDANE
From the company
Corvidane is a privately held life sciences company developing novel therapeutic approaches for cardiometabolic disease, including atherosclerosis and metabolic dysfunction associated steatohepatitis (MASH). Its lead programme, CVMB-216, is a patented orally administered, multi-pathway therapeutic that activates a spectrum of clinically validated targets spanning lipid metabolism, inflammation and fibrosis. The company advances programmes through structured preclinical development toward regulated clinical pathways and pursues two indications for FDA app
Products & services offered
Capabilities 6
Classifications
- Ownership classifications (2)
- Black American Owned, Minority Owned Business
Facilities
Send your requirements
Quantities, certifications, and timing.